Back to Journals
Dr Gonzalez de la Parra
Mario Gonzalez de la Parra, Scientific Director, Biokinetics, S.A. de C.V, Mexico City, Mexico.
John Haughney, Associate Director, Clinical R&D, NHS Greater Glasgow and Clyde, Glasgow UK; Senior Research fellow, University of Aberdeen, Aberdeen UK
Sabzali Javadov, Professor, Department of Physiology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA.
Amanda Lee, Director of Institute of Applied Health Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, Scotland, UK.
Kyu Lim, Professor, Department of Biochemistry, College of Medicine, Cancer Research Institute, Infection Signaling Network Research Center, Chungnam National University, Korea.
Christoph R. Meier, Professor, Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland
Arshag D. Mooradian, Professor of Medicine, Chairman, Department of Medicine, University of Florida, Jacksonville, Florida, USA.
Prof. Dr. Mosnaim
Aron D. Mosnaim, Professor, Department of Cellular and Molecular Pharmacology and of Psychiatry and Behavioral Sciences, Chicago Medical School at Rosalind University of Medicine and Science, North Chicago, Illinois, USA; Honorary Professor, College of Pharmacy at the University of Chile, Santiago, Chile
Emilio Perucca, Professor of Pharmacology, University of Pavia, Director of the Clinical Trial Centre at the Institute of Neurology IRCCS C. Mondino Foundation, Pavia, Italy.
Dr Van Boven
Dr Job FM van Boven, Assistant Professor of Health Economics & Real-World (drug) Outcomes, Department of Clinical Pharmacy & Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, The Netherlands.
Professor van der Molen
T. van der Molen, Professor, Department of General Practice, University of Groningen, The Netherlands